{"id":316889,"date":"2026-10-19T14:35:53","date_gmt":"2026-10-19T09:05:53","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=316889"},"modified":"2026-10-19T14:35:53","modified_gmt":"2026-10-19T09:05:53","slug":"formulation-major-infusion-set-maker-and-pizza-chain-stocks-roadmap-keystone-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/formulation-major-infusion-set-maker-and-pizza-chain-stocks-roadmap-keystone-list\/","title":{"rendered":"3 Formulation Major, Infusion Set Maker and Pizza Chain Stocks With a Strong Future Roadmap: Aurobindo Pharma, Poly Medicure and Jubilant FoodWorks"},"content":{"rendered":"

Aurobindo Pharma Rs 1,666.90, P\/E 25.46. Poly Medicure Rs 1,593.80, P\/E 51.87. Jubilant FoodWorks Rs 417.95, P\/E 62.77. Closing prices of 14 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Formulation major, infusion set maker and pizza chain stocks with the clearest long-term roadmaps today include Aurobindo Pharma in generic formulations and active ingredients sold in the US, Europe and emerging markets, Poly Medicure in medical devices such as infusion sets, needles, catheters and dialysis products sold in India and many export markets and Jubilant FoodWorks in Domino’s Pizza stores across India and neighbouring markets, along with newer food brands. FY26 revenue growth was 5.6% at Aurobindo Pharma, 13.4% at Poly Medicure and 17.2% at Jubilant FoodWorks. P\/E stands at 25.46 for Aurobindo Pharma (industry 37.59), 51.87 for Poly Medicure (industry 62.79) and 62.77 for Jubilant FoodWorks (industry 61.79). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.<\/p>\n<\/p><\/div>\n

Formulation major, infusion set maker and pizza chain stocks give investors exposure to medicines, hospital supplies and eating out. Volumes, export demand and margins decide how much of that demand turns into profit.<\/p>\n

Readers comparing formulation major, infusion set maker and pizza chain stocks should weigh growth, margins, cash flow and valuation together instead of leaning on any single number.<\/p>\n

This list covers three formulation major, infusion set maker and pizza chain stocks: Aurobindo Pharma for generic formulations and active ingredients sold in the US, Europe and emerging markets, Poly Medicure for medical devices such as infusion sets, needles, catheters and dialysis products sold in India and many export markets and Jubilant FoodWorks for Domino’s Pizza stores across India and neighbouring markets, along with newer food brands. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n